<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>4272910</identifier>
<setSpec>0300-9041</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Cervantes, A</dc:author>
<dc:author>Maqueo, M</dc:author>
<dc:author>Gorodovsky, J</dc:author>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:subject>Headache</dc:subject>
<dc:subject>Use-effectiveness</dc:subject>
<dc:subject>Contraceptive Agents</dc:subject>
<dc:subject>Contraceptive Agents, Progestin</dc:subject>
<dc:subject>Nervousness</dc:subject>
<dc:subject>Contraception</dc:subject>
<dc:subject>Family Planning</dc:subject>
<dc:subject>Research Methodology</dc:subject>
<dc:subject>Bleeding</dc:subject>
<dc:subject>Contraceptive Effectiveness</dc:subject>
<dc:subject>Diseases</dc:subject>
<dc:subject>Metrorrhagia</dc:subject>
<dc:subject>Dizziness</dc:subject>
<dc:subject>Menstruation Disorders</dc:subject>
<dc:subject>Norethindrone</dc:subject>
<dc:subject>Norethindrone Enanthate</dc:subject>
<dc:subject>Clinical Research</dc:subject>
<dc:subject>Amenorrhea</dc:subject>
<dc:subject>Signs And Symptoms</dc:subject>
<dc:subject>Reversibility</dc:subject>
<dc:subject>Injectables</dc:subject>
<dc:subject>Medroxyprogesterone Acetate</dc:subject>
<dc:subject>Contraceptive Agents, Female</dc:subject>
<dc:date>1973 Oct </dc:date>
<dc:title xml:lang="es">Anticonceptivos inyectables. Diez años de experiencia clínica.</dc:title>
<dc:title xml:lang="en">[Injectable contraceptives. 10 years' clinical experience].</dc:title>
<dc:publisher>Ginecologia y obstetricia de Mexico</dc:publisher>
</metadata>
</record>
</pubmed-document>
